APA (7th ed.) Citation

ZH, L., LM, D., XZ, F., W, J., SW, S., Y, S., . . . Y, Y. (2026). Efgartigimod as Rescue Therapy for PD-1 Inhibitor-Associated Myasthenia Gravis, Myocarditis, and Myositis (MMM) Syndrome: A 2-Case Report and Literature Review. The American journal of case reports, 27, e951872. https://doi.org/10.12659/AJCR.951872

Chicago Style (17th ed.) Citation

ZH, Liu, Duan LM, Fang XZ, Jiang W, Sun SW, Shang Y, Huang CL, and Yuan Y. "Efgartigimod as Rescue Therapy for PD-1 Inhibitor-Associated Myasthenia Gravis, Myocarditis, and Myositis (MMM) Syndrome: A 2-Case Report and Literature Review." The American Journal of Case Reports 27 (2026): e951872. https://doi.org/10.12659/AJCR.951872.

MLA (9th ed.) Citation

ZH, Liu, et al. "Efgartigimod as Rescue Therapy for PD-1 Inhibitor-Associated Myasthenia Gravis, Myocarditis, and Myositis (MMM) Syndrome: A 2-Case Report and Literature Review." The American Journal of Case Reports, vol. 27, 2026, p. e951872, https://doi.org/10.12659/AJCR.951872.